The benchmark EGX30 dipped 0.76 percent, or 87.12 points, to end at 11,451.14 points.
The benchmark EGX30 rose 0.20 percent, or 23.39 points, to end at 11,538.26 points.
The benchmark EGX30 rose 0.73 percent, or 82.98 points, to end at 11,401.33 points.
The benchmark EGX30 rose 0.21 percent, or 24.4 points, to end at 11,420 points.
The benchmark EGX30 rose 1.63 percent, or 183.3 points, to end at 11,395.6 points.
The benchmark EGX30 dropped 1.34 percent, or 153.41 points, to end at 11,277.83 points.
The benchmark EGX30 dropped 0.57 percent, or 64.88 points, to end at 11,273.11 points.
The benchmark EGX30 hiked 0.35 percent, or 40.09 points, to end at 11,453.3 points.
The benchmark EGX30 dropped 0.73 percent, or 83.42 points, to end at 11,413.21 points.
The benchmark EGX30 dropped 1.43 percent, or 166.36 points, to end at 11,496.63 points.
According to Vodafone group statement, it’s expected to finalize the deal in March 2022.
The benchmark EGX30 dropped 0.93 percent, or 107.92 points, to end at 11,480.5 points.
The benchmark EGX30 hiked 0.79 percent, or 90.91 points, to end at 11,588.42 points.
The benchmark EGX30 decreased 0.50 percent, or 58.07 points, to end at 11,497.51 points.
The benchmark EGX30 decreased 0.49 percent, or 57.26 points, to end at 11,555.58 points.
The benchmark EGX30 decreased 0.62 percent, or 72.28 points, to end at 11,612.84 points.
Manufacturing in Egypt is part of AstraZeneca's commitment to support the local healthcare system and representative of its investment in the region, he stated.
The benchmark EGX30 inched up 0.07 percent, or 8.74 points, to end at 11,685.12 points.
The benchmark EGX30 hiked 0.93 percent, or 108.11 points, to end at 11,676.38 points.
The benchmark EGX30 hiked 1.30 percent, or 148.08 points, to end at 11,568.27 points.
